Outcomes for Patients with Residual Stage II/III Breast Cancer Following Neoadjuvant Chemotherapy (AFT-01). Stankowski-Drengler TJ, Schumacher JR, Hanlon B, Livingston-Rosanoff D, et al. Ann Surg Oncol 2020 Jan 3. pii: 10.1245/s10434-019-07846.

Read + Share

Amedeo Smart

Independent Medical Education

Stankowski-Drengler TJ, Schumacher JR, Hanlon B, Livingston-Rosanoff D, et al. Outcomes for Patients with Residual Stage II/III Breast Cancer Following Neoadjuvant Chemotherapy (AFT-01). Ann Surg Oncol 2020 Jan 3. pii: 10.1245/s10434-019-07846.
PMID: 31900808